Attorney Advertising. The law firm of Wolf Haldenstein Adler Freeman & Herz LLP is investigating possible breaches of fiduciary duty by the Board of Directors of IMS Health, Inc. ("IMS" or the "Company") [NYSE:RX] arising out of the proposed acquisition of IMS by TPG Capital ("TPG") and the CPP Investment Board ("CPPIB").